AAAAAA

   
Results: 1-8 |
Results: 8
CYTOKINE GENE-MODIFIED TUMOR-CELLS FOR PROPHYLACTIC AND THERAPEUTIC VACCINATION - IL-2, IFN-GAMMA, OR COMBINATION IL-2-GAMMA(IFN)
Authors: KIRCHEIS R KUPCU Z WALLNER G WAGNER E
Citation: R. Kircheis et al., CYTOKINE GENE-MODIFIED TUMOR-CELLS FOR PROPHYLACTIC AND THERAPEUTIC VACCINATION - IL-2, IFN-GAMMA, OR COMBINATION IL-2-GAMMA(IFN), Cytokines cellular & molecular therapy, 4(2), 1998, pp. 95-103
SUSTAINED CYTOKINE DELIVERY FOR ANTICANCER VACCINATION - LIPOSOMES ASALTERNATIVE FOR GENE-TRANSFECTED TUMOR-CELLS
Authors: KOPPENHAGEN FJ KUPCU Z WALLNER G CROMMELIN DJA WAGNER E STORM G KIRCHEIS R
Citation: Fj. Koppenhagen et al., SUSTAINED CYTOKINE DELIVERY FOR ANTICANCER VACCINATION - LIPOSOMES ASALTERNATIVE FOR GENE-TRANSFECTED TUMOR-CELLS, Clinical cancer research, 4(8), 1998, pp. 1881-1886
THE SIZE OF DNA TRANSFERRIN-PEI COMPLEXES IS AN IMPORTANT FACTOR FOR GENE-EXPRESSION IN CULTURED-CELLS/
Authors: OGRIS M STEINLEIN P KURSA M MECHTLER K KIRCHEIS R WAGNER E
Citation: M. Ogris et al., THE SIZE OF DNA TRANSFERRIN-PEI COMPLEXES IS AN IMPORTANT FACTOR FOR GENE-EXPRESSION IN CULTURED-CELLS/, Gene therapy, 5(10), 1998, pp. 1425-1433
INCREASE OF PROLIFERATION RATE AND ENHANCEMENT OF ANTITUMOR CYTOTOXICITY OF EXPANDED HUMAN CD3(-CELLS BY RECEPTOR-MEDIATED TRANSFECTION WITH THE INTERLEUKIN-7 GENE()CD56(+) IMMUNOLOGICAL EFFECTOR)
Authors: FINKE S TROJANECK B LEFTEROVA P CSIPAI M WAGNER E KIRCHEIS R NEUBAUER A HUHN D WITTIG B SCHMIDTWOLF IGH
Citation: S. Finke et al., INCREASE OF PROLIFERATION RATE AND ENHANCEMENT OF ANTITUMOR CYTOTOXICITY OF EXPANDED HUMAN CD3(-CELLS BY RECEPTOR-MEDIATED TRANSFECTION WITH THE INTERLEUKIN-7 GENE()CD56(+) IMMUNOLOGICAL EFFECTOR), Gene therapy, 5(1), 1998, pp. 31-39
COUPLING OF CELL-BINDING LIGANDS TO POLYETHYLENIMINE FOR TARGETED GENE DELIVERY
Authors: KIRCHEIS R KICHLER A WALLNER G KURSA M OGRIS M FELZMANN T BUCHBERGER M WAGNER E
Citation: R. Kircheis et al., COUPLING OF CELL-BINDING LIGANDS TO POLYETHYLENIMINE FOR TARGETED GENE DELIVERY, Gene therapy, 4(5), 1997, pp. 409-418
LYMPHOCYTE APOPTOSIS - INDUCTION BY GENE-TRANSFER TECHNIQUES
Authors: EBERT O FINKE S SALAHI A HERRMANN M TROJANECK B LEFTEROVA P WAGNER E KIRCHEIS R HUHN D SCHRIEVER F SCHMIDTWOLF IGH
Citation: O. Ebert et al., LYMPHOCYTE APOPTOSIS - INDUCTION BY GENE-TRANSFER TECHNIQUES, Gene therapy, 4(4), 1997, pp. 296-302
EX-VIVO GENE-TRANSFER INTO NEUROBLASTOMA-CELLS FOR THE DEVELOPMENT OFTUMOR VACCINATION STRATEGIES
Authors: BUCHBERGER M KIRCHEIS R WAGNER E GADNER H FELZMANN T
Citation: M. Buchberger et al., EX-VIVO GENE-TRANSFER INTO NEUROBLASTOMA-CELLS FOR THE DEVELOPMENT OFTUMOR VACCINATION STRATEGIES, Cancer gene therapy, 3(6), 1996, pp. 26-26
ENHANCEMENT OF ANTITUMOR CYTOTOXICITY OF HUMAN IMMUNOLOGICAL EFFECTOR-CELLS BY TRANSFECTION WITH THE INTERLEUKIN-7 GENE
Authors: FINKE S TROJANECK B LEFTEROVA P CSIPAI M KRUOPIS S WAGNER E KIRCHEIS R NEUBAUER A HUHN D WITTIG B SCHMIDTWOLF IGH
Citation: S. Finke et al., ENHANCEMENT OF ANTITUMOR CYTOTOXICITY OF HUMAN IMMUNOLOGICAL EFFECTOR-CELLS BY TRANSFECTION WITH THE INTERLEUKIN-7 GENE, Blood, 88(10), 1996, pp. 3889-3889
Risultati: 1-8 |